A Novel Anticancer Ribonucleoside, 1-(3-C-Ethynyl-β-D-ribo-pentofuranosyl)Cytosine, Enhances Radiation-Induced Cell Death in Tumor Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Novel Anticancer Ribonucleoside, 1-(3-C-Ethynyl-β-D-ribo-pentofuranosyl)Cytosine, Enhances Radiation-Induced Cell Death in Tumor Cells

Published:2004-12 Issue:6 Volume:162 Page:635-645
ISSN:0033-7587
Container-title:Radiation Research
language:en
Short-container-title:Radiation Research

Author:

Inanami Osamu,Iizuka Daisuke,Iwahara Akiko,Yamamori Tohru,Kon Yasuhiro,Asanuma Taketoshi,Matsuda Akira,Kashiwakura Ikuo,Kitazato Kenji,Kuwabara Mikinori

Publisher

Radiation Research Society

Subject

Radiology Nuclear Medicine and imaging,Radiation,Biophysics

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleoside analogs as a radiosensitizer modulating DNA repair, cell cycle checkpoints, and apoptosis;Nucleosides, Nucleotides & Nucleic Acids;2019-09-27

2. Manganese-Enhanced MRI Reveals Early-Phase Radiation-Induced Cell Alterations In Vivo;Cancer Research;2013-05-21

3. Phase II study of TAS ‐106 in patients with platinum‐failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer;Cancer Medicine;2013-04-18

4. TAS-106: Preclinical, Clinical and Beyond;Oncology;2013

5. A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression;Molecular Cancer;2011-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP